How Can Drug Metabolism and Transporter Genetics Inform Psychotropic Prescribing?
Open Access
- 8 December 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Genetics
Abstract
Many genetic variants in drug metabolizing enzymes and transporters have been shown to be relevant for treating psychiatric disorders. Associations are strong enough to feature on drug labels and for prescribing guidelines based on such data. A range of commercial tests are available; however, there is variability in included genetic variants, methodology, and interpretation. We herein provide relevant background for understanding clinical associations with specific variants, other factors that are relevant to consider when interpreting such data (such as age, gender, drug-drug interactions), and summarize the data relevant to clinical utility of pharmacogenetic testing in psychiatry and the available prescribing guidelines. We also highlight areas for future research focus in this field.Funding Information
- Alberta Innovates (G2018000868)
This publication has 432 references indexed in Scilit:
- Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic AntidepressantsClinical Pharmacology & Therapeutics, 2013
- Genetic variation in CYP3A43 explains racial difference in olanzapine clearanceMolecular Psychiatry, 2011
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine DosingClinical Pharmacology & Therapeutics, 2011
- CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research NetworkClinical Pharmacology & Therapeutics, 2011
- Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CARAdvanced Drug Delivery Reviews, 2010
- Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugsThe Pharmacogenomics Journal, 2010
- Analysis of humanCYP1A1andCYP1A2genes and their shared bidirectional promoter in eight world populationsHuman Mutation, 2009
- The Role of COMT Val158Met in CognitionBiological Psychiatry, 2009
- Illicit drug use in young adults and subsequent decline in general health: The Coronary Artery Risk Development in Young Adults (CARDIA) StudyDrug and Alcohol Dependence, 2007
- A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressantsClinical Pharmacology & Therapeutics, 2006